Wordt geladen...
Rethinking immune checkpoint blockade: ‘Beyond the T cell’
The clinical success of immune checkpoint inhibitors has highlighted the central role of the immune system in cancer control. Immune checkpoint inhibitors can reinvigorate anti-cancer immunity and are now the standard of care in a number of malignancies. However, research on immune checkpoint blocka...
Bewaard in:
| Gepubliceerd in: | J Immunother Cancer |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817791/ https://ncbi.nlm.nih.gov/pubmed/33468555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001460 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|